Incorporating nanotechnology into the field of cardiovascular medicine is paving the way for new treatments that were once unimaginable. Nanotechnology and cardiovascular medicine are being combined to develop more precise drug delivery systems, allowing medication to be delivered directly to the heart, reducing systemic side effects and improving therapeutic outcomes. This breakthrough is also enhancing diagnostic tools, enabling earlier detection of cardiovascular diseases. The potential for nanomaterials to repair or regenerate damaged tissues and blood vessels provides a hopeful outlook for patients suffering from severe cardiovascular diseases. As this field continues to evolve, the integration of nanotechnology promises to redefine the future of heart disease management.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom